Jpmorgan Chase & CO Tela Bio, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TELA
# of Institutions
55Shares Held
18.3MCall Options Held
759KPut Options Held
100-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$12.4 Million2.98% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.47MShares$7.43 Million2.52% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.16MShares$6.51 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.92MShares$5.76 Million0.29% of portfolio
-
Silverarc Capital Management, LLC1.12MShares$3.39 Million0.71% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $57.7M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...